Combination treatment modalities in cutaneous T-cell lymphoma (CTCL)

Seminars in Oncology

Volumn 33, Issue SUPPL. 3, 2006, Pages 17-20

  Guitart, Joan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTILIPEMIC AGENT; BEXAROTENE; CARMUSTINE; EMOLLIENT AGENT; GAMMA INTERFERON; IMIQUIMOD; PSORALEN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RETINOID; RETINOID X RECEPTOR; STEROID; TAZAROTENE; THYROID HORMONE;

CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; IMMUNOSTIMULATION; MONOTHERAPY; MYCOSIS FUNGOIDES; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; QUALITY OF LIFE; REVIEW; SKIN ATROPHY; SKIN CANCER; SKIN IRRITATION; SYSTEMIC THERAPY; TOPICAL TREATMENT; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 33644560263     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.12.018     Document Type: Article

References (19)

1. H.S. Zackheim, M. Kashani-Sabet, S. Amin Topical corticosteroids for mycosis fungoides Experience in 79 patients Arch Dermatol 34 1998 949 954
2. Y.H. Kim, G. Martinez, A. Varghese Topical nitrogen mustard in the management of mycosis fungoides Update of the Stanford experience Arch Dermatol 139 2003 165 173
3. J. de Quatrebarbes, E. Esteve, M. Bagot Treatment of early stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids Arch Dermatol 141 2005 1117 1120
4. N. Apisarnthanarax, R. Talpur, S. Ward Tazarotene 0.1% gel for refractory mycosis fungoides lesions an open-label pilot study J Am Acad Dermatol 50 2004 600 607
5. D. Breneman, M. Duvic, T. Kuzel Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma Arch Dermatol 138 2002 325 332
6. K.R. Suchin, A.J. Cucchiara, S.L. Gottleib Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy A 14-year experience at a single institution Arch Dermatol 138 2002 1054 1060
7. T.M. Kuzel, H.H. Roenigk Jr, E. Samuelson Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome J Clin Oncol 13 1995 257 263
8. V. Chiarion-Sileni, A. Bononi, C.V. Fornasa Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma Cancer 95 2002 569 575
9. K. Thomsen, H. Hammar, L. Molin Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage A report from the Scandinavian Mycosis Fungoides Group Acta Derm Venereol 69 1989 536 538
10. M. Duvic, A.G. Martin, Y. Kim Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma Arch Dermatol 137 2001 581 593
11. M. Duvic, K. Hymes, P. Heald Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma Multinational phase II-III trial results J Clin Oncol 19 2001 2456 2471
12. R. Talpur, S. Ward, N. Apisarnthanarax Optimizing bexarotene therapy for cutaneous T-cell lymphoma J Am Acad Dermatol 47 2002 672 684
13. F. Singh, M.G. Lebwohl Cutaneous T-cell lymphoma treatment using bexarotene and PUVA A case series J Am Acad Dermatol 51 2004 570 573
14. P. Heald, M. Mehlmauer, A.G. Martin Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma Results of the phase III clinical trial J Am Acad Dermatol 49 2003 801 815
15. D.K. Stern, M. Lebwohl Treatment of mycosis fungoides with oral bexarotene combined with PUVA J Drugs Dermatol 1 2002 134 136
16. K.S. McGinnis, M. Shapiro, C.C. Vittorio Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma Arch Dermatol 139 2003 771 775
17. K.K. Hermann, H.H. Roenigk Jr, A. Hurria Treatment of mycosis fungoides with photochemotherapy (PUVA) Long-term follow-up J Am Acad Dermatol 33 1995 234 242
18. L.E. French, M. Shapiro, J.M. Junkins-Hopkins Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy J Am Acad Dermatol 45 2001 914 918
19. K.S. McGinnis, J.M. Junkins-Hopkins, G. Crawford Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma Clinical synergism and possible immunologic mechanisms J Am Acad Dermatol 50 2004 375 379